Nektar Therapeutics announced a $30 million private placement financing with TCGX
Amount Raised
$30 Million
Round Type
Post-IPO Equity
San FranciscoBiotechnologyHealth CareInvestors
Description
Nektar Therapeutics announced a private placement financing with TCGX, an institutional accredited investor, to sell securities for gross proceeds of $30 million. The financing is expected to close on or before March 6, 2024.
Quick answer
Nektar Therapeutics raised $30 Million in a Post-IPO Equity round, dated March 4, 2024. Investors: Tcgx. Nektar Therapeutics is based in San Francisco, California, United States.
- How much did Nektar Therapeutics raise?
- Nektar Therapeutics raised $30 Million in a Post-IPO Equity round on March 4, 2024.
- Who invested in Nektar Therapeutics?
- Tcgx is named as investors in this round.
- What does Nektar Therapeutics do?
- Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need.
- Where is Nektar Therapeutics based and how big is it?
- Nektar Therapeutics is based in San Francisco, California, United States. Fundz records about 61 employees.
- Who are the decision-makers at Nektar Therapeutics?
- Fundz holds 2 contacts at Nektar Therapeutics, including the Senior Vice President, Chief Medical Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Nektar Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Outrun Therapeutics raised $10M (Seed) on April 18, 2024.
- HealthSage raised $3.2M (Seed) on April 17, 2024.
- Theolytics raised $25M (Funding Round) on April 17, 2024.
- Isospec Analytics raised $1.9M (Pre-Seed) on April 16, 2024.
- OsseoLabs raised $2M (Series A) on April 15, 2024.
- Harvard Apparatus Regenerative Technology raised $1.5M on April 15, 2024.
Who to call at Nektar Therapeutics, and when
A new round usually means Nektar Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nektar Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nektar Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nektar Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nektar Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nektar Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.